Home
About
Overview
Sharing Data
ORCID
Help
History (57)
Estrogen Receptor Modulators
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension.
Survival of Motor Neuron 2 Protein
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
See All 57 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
Landreth G, Jiang Q, Mandrekar S, Heneka M. PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics. 2008 Jul; 5(3):481-9.
View in:
PubMed
subject areas
Alzheimer Disease
Animals
Antipsychotic Agents
Humans
PPAR gamma
authors with profiles
Michael Thomas Heneka MD